Acute myelomonoblastic leukemia in a patient with multiple myeloma.

Acta medica Iugoslavica Pub Date : 1989-01-01

M Colović, V Jovanović, M Ristić

引用次数: 0

Abstract

A 40-year-old man who developed acute myelomonoblastic leukemia (M4) after 7 years of treatment for multiple myeloma with the alkylating agent melphalan and steroids is presented. Leukemia was treated with courses of adriblastin, cytosine arabinoside, and thioguanin (DAT protocol), with a 8 months' survival.

本刊更多论文

多发性骨髓瘤患者的急性髓母细胞白血病。

一位40岁的男性在接受烷基化剂melphalan和类固醇治疗多发性骨髓瘤7年后发展为急性髓母细胞白血病(M4)。白血病采用阿替布汀、阿糖胞嘧啶和硫鸟苷(DAT方案)治疗，生存期为8个月。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta medica Iugoslavica

自引率

0.00%

发文量